View in EDS HTML Full Text PDF Full Text

Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).

Saved in:
Bibliographic Details
Title: Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
Authors: Ri M; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan. rrmasaki@med.nagoya-cu.ac.jp., Iida S; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan., Saito K; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan., Saito Y; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan., Maruyama D; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Asano A; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan., Fukuhara S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan., Tsujimura H; Department of Hematology and Medical Oncology, Chiba Cancer Center, Chiba, Japan., Miyazaki K; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan., Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan., Fukuhara N; Department of Hematology, Tohoku University Hospital, Sendai, Japan., Negoro E; Department of Hematology and Oncology, University of Fukui Hospital, Fukui, Japan., Kuroda J; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan., Yoshida S; Department of Hematology, NHO Nagasaki Medical Center, Nagasaki, Japan., Ohtsuka E; Department of Hematology, Oita Prefectural Hospital, Oita, Japan., Norifumi T; Department of Hematology, Gunma University, Maebashi, Japan., Tabayashi T; Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan., Takayama N; Department of Hematology, Kyorin University Faculty of Medicine, Mitaka, Japan., Saito T; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan., Suzuki Y; Department of Hematology, NHO Nagoya Medical Center, Nagoya, Japan., Harada Y; Department of Hematology, Toyota Kosei Hospital, Toyota, Japan., Mizuno I; Division of Hematology, Hyogo Cancer Center, Akashi, Japan., Yoshida I; Department of Hematologic Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan., Maruta M; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Matsuyama, Japan., Takamatsu Y; Division of Medical Oncology, Hematology and Infectious Diseases, Fukuoka University Hospital, Fukuoka, Japan., Katsuya H; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan., Yoshimitsu M; Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan., Minami Y; Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan., Kanato K; JCOG Data Center/Operating Office, National Cancer Center Hospital, Tokyo, Japan., Munakata W; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan., Nagai H; Department of Hematology, NHO Nagoya Medical Center, Nagoya, Japan.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2025 Jan 24; Vol. 95 (1), pp. 29. Date of Electronic Publication: 2025 Jan 24.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39853402
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ri+M%22">Ri M</searchLink>; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan. rrmasaki@med.nagoya-cu.ac.jp.<br /><searchLink fieldCode="AU" term="%22Iida+S%22">Iida S</searchLink>; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Saito+K%22">Saito K</searchLink>; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Saito+Y%22">Saito Y</searchLink>; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Maruyama+D%22">Maruyama D</searchLink>; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Asano+A%22">Asano A</searchLink>; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuhara+S%22">Fukuhara S</searchLink>; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Tsujimura+H%22">Tsujimura H</searchLink>; Department of Hematology and Medical Oncology, Chiba Cancer Center, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Miyazaki+K%22">Miyazaki K</searchLink>; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.<br /><searchLink fieldCode="AU" term="%22Ota+S%22">Ota S</searchLink>; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuhara+N%22">Fukuhara N</searchLink>; Department of Hematology, Tohoku University Hospital, Sendai, Japan.<br /><searchLink fieldCode="AU" term="%22Negoro+E%22">Negoro E</searchLink>; Department of Hematology and Oncology, University of Fukui Hospital, Fukui, Japan.<br /><searchLink fieldCode="AU" term="%22Kuroda+J%22">Kuroda J</searchLink>; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+S%22">Yoshida S</searchLink>; Department of Hematology, NHO Nagasaki Medical Center, Nagasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Ohtsuka+E%22">Ohtsuka E</searchLink>; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.<br /><searchLink fieldCode="AU" term="%22Norifumi+T%22">Norifumi T</searchLink>; Department of Hematology, Gunma University, Maebashi, Japan.<br /><searchLink fieldCode="AU" term="%22Tabayashi+T%22">Tabayashi T</searchLink>; Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.<br /><searchLink fieldCode="AU" term="%22Takayama+N%22">Takayama N</searchLink>; Department of Hematology, Kyorin University Faculty of Medicine, Mitaka, Japan.<br /><searchLink fieldCode="AU" term="%22Saito+T%22">Saito T</searchLink>; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+Y%22">Suzuki Y</searchLink>; Department of Hematology, NHO Nagoya Medical Center, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Harada+Y%22">Harada Y</searchLink>; Department of Hematology, Toyota Kosei Hospital, Toyota, Japan.<br /><searchLink fieldCode="AU" term="%22Mizuno+I%22">Mizuno I</searchLink>; Division of Hematology, Hyogo Cancer Center, Akashi, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+I%22">Yoshida I</searchLink>; Department of Hematologic Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan.<br /><searchLink fieldCode="AU" term="%22Maruta+M%22">Maruta M</searchLink>; Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Matsuyama, Japan.<br /><searchLink fieldCode="AU" term="%22Takamatsu+Y%22">Takamatsu Y</searchLink>; Division of Medical Oncology, Hematology and Infectious Diseases, Fukuoka University Hospital, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Katsuya+H%22">Katsuya H</searchLink>; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshimitsu+M%22">Yoshimitsu M</searchLink>; Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan.<br /><searchLink fieldCode="AU" term="%22Minami+Y%22">Minami Y</searchLink>; Department of Hematology, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Kanato+K%22">Kanato K</searchLink>; JCOG Data Center/Operating Office, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Munakata+W%22">Munakata W</searchLink>; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nagai+H%22">Nagai H</searchLink>; Department of Hematology, NHO Nagoya Medical Center, Nagoya, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2025 Jan 24; Vol. 95 (1), pp. 29. <i>Date of Electronic Publication: </i>2025 Jan 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39853402
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-025-04752-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 29
    Titles:
      – TitleFull: Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ri M
      – PersonEntity:
          Name:
            NameFull: Iida S
      – PersonEntity:
          Name:
            NameFull: Saito K
      – PersonEntity:
          Name:
            NameFull: Saito Y
      – PersonEntity:
          Name:
            NameFull: Maruyama D
      – PersonEntity:
          Name:
            NameFull: Asano A
      – PersonEntity:
          Name:
            NameFull: Fukuhara S
      – PersonEntity:
          Name:
            NameFull: Tsujimura H
      – PersonEntity:
          Name:
            NameFull: Miyazaki K
      – PersonEntity:
          Name:
            NameFull: Ota S
      – PersonEntity:
          Name:
            NameFull: Fukuhara N
      – PersonEntity:
          Name:
            NameFull: Negoro E
      – PersonEntity:
          Name:
            NameFull: Kuroda J
      – PersonEntity:
          Name:
            NameFull: Yoshida S
      – PersonEntity:
          Name:
            NameFull: Ohtsuka E
      – PersonEntity:
          Name:
            NameFull: Norifumi T
      – PersonEntity:
          Name:
            NameFull: Tabayashi T
      – PersonEntity:
          Name:
            NameFull: Takayama N
      – PersonEntity:
          Name:
            NameFull: Saito T
      – PersonEntity:
          Name:
            NameFull: Suzuki Y
      – PersonEntity:
          Name:
            NameFull: Harada Y
      – PersonEntity:
          Name:
            NameFull: Mizuno I
      – PersonEntity:
          Name:
            NameFull: Yoshida I
      – PersonEntity:
          Name:
            NameFull: Maruta M
      – PersonEntity:
          Name:
            NameFull: Takamatsu Y
      – PersonEntity:
          Name:
            NameFull: Katsuya H
      – PersonEntity:
          Name:
            NameFull: Yoshimitsu M
      – PersonEntity:
          Name:
            NameFull: Minami Y
      – PersonEntity:
          Name:
            NameFull: Kanato K
      – PersonEntity:
          Name:
            NameFull: Munakata W
      – PersonEntity:
          Name:
            NameFull: Nagai H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 01
              Text: 2025 Jan 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0843
          Numbering:
            – Type: volume
              Value: 95
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1